COMPARISON OF RENAL DYSFUNCTION IN SYSTOLIC HEART FAILURE PATIENTS TREATED WITH SACUBITRIL-VALSARTAN OR ACE INHIBITOR/ANGIOTENSIN RECEPTOR BLOCKER

被引:1
|
作者
Tan, Nicholas [1 ]
Deng, Yihong [1 ]
Yao, Xiaoxi [1 ]
Sangaralingham, LIndsey [1 ]
Shah, Nilay [1 ]
Rule, Andrew [1 ]
Burnett, John [1 ]
Dunlay, Shannon [1 ]
Sangaralingham, Jeson [1 ]
机构
[1] Mayo Clin, Rochester, MN USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1415-77
引用
收藏
页码:1023 / 1023
页数:1
相关论文
共 50 条
  • [1] The impact of discontinuation of sacubitril-valsartan and shifting to angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in patients with heart failure with reduced ejection fraction
    Amin, Osama A.
    Alaarag, Ahmed F.
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2021, 25 (03): : 163 - 169
  • [2] COMPARATIVE EFFECTIVENESS OF SACUBITRIL-VALSARTAN VERSUS ANGIOTENSIN CONVERTING ENZYME INHIBITORS / ANGIOTENSIN RECEPTOR BLOCKERS THERAPY ON RENAL OUTCOMES IN SYSTOLIC HEART FAILURE PATIENTS
    Deng, Y.
    Tan, N. Y.
    Yao, X.
    Sangaralingham, L.
    Shah, N. D.
    Rule, A. D.
    Burnett, J. C.
    Dunlay, S. M.
    Sangaralingham, S. J.
    VALUE IN HEALTH, 2020, 23 : S92 - S92
  • [3] Changes in hemodynamic profile in patients with severe systolic dysfunction treated with sacubitril-valsartan
    Corazza, F.
    Ceccarelli, A.
    Vitale, G.
    Boschi, S.
    Giovannini, L.
    Masetti, M.
    Russo, A.
    Potena, L. Luciano
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 422 - 422
  • [4] Sacubitril-valsartan in heart failure and multimorbidity patients
    Rodil Fraile, Raquel
    Malafarina, Vincenzo
    Tiberio Lopez, Gregorio
    ESC HEART FAILURE, 2018, 5 (05): : 957 - 960
  • [5] EFFECTS OF SACUBITRIL-VALSARTAN COMPARED TO ACE INHIBITORS/ANGIOTENSIN RECEPTOR BLOCKERS ON RENAL OUTCOMES IN PATIENTS WITH HEART FAILURE: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Generoso, Eloisa Trina
    Dimagiba, Enrique
    Crisostomo, Jacqueline
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (04) : 573 - 573
  • [6] SACUBITRIL-VALSARTAN VERSUS ANGIOTENSIN CONVERTING ENZYME INHIBITORS OR ANGIOTENSIN RECEPTOR BLOCKERS IN SYSTOLIC HEART FAILURE: COMPARATIVE OUTCOMES IN CLINICAL PRACTICE
    Tan, Nicholas
    Sangaralingham, Lindsey
    Sangaralingham, Jeson
    Yao, Xiaoxi
    Shah, Nilay
    Dunlay, Shannon
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 776 - 776
  • [7] Effectiveness of sacubitril-valsartan in cancer patients with heart failure
    Martin-Garcia, Ana
    Lopez-Fernandez, Teresa
    Mitroi, Cristina
    Chaparro-Munoz, Marinela
    Moliner, Pedro
    Martin-Garcia, Agustin C.
    Martinez-Monzonis, Amparo
    Castro, Antonio
    Lopez-Sendon, Jose L.
    Sanchez, Pedro L.
    ESC HEART FAILURE, 2020, 7 (02): : 763 - 767
  • [8] Left Ventricular Function Improves in Heart Failure Patients Treated With Sacubitril-Valsartan
    Nazzari, Hamed
    Yeung, Michael
    Marceau, Aude
    Luong, Michael
    Clark, Catherine
    Ahuja, Stephanie
    Knoll, Jennifer
    Koscal, Mirka
    Davis, Margot
    Virani, Sean
    Ignaszewski, Andrew
    Toma, Mustafa
    CIRCULATION, 2017, 136
  • [9] Eligibility for sacubitril-valsartan in patients with acute decompensated heart failure
    Carballo, David
    Stirnemann, Jerome
    Garin, Nicolas
    Marti, Chistophe
    Serratrice, Jacques
    Carballo, Sebastian
    ESC HEART FAILURE, 2020, 7 (03): : 1282 - 1290
  • [10] Mortality and Heart Failure Risk Reductions in Patients Treated With Sacubitril-Valsartan in Clinical Trials
    Cordero, Alberto
    Nunez, Julio
    Bertomeu-Gonzalez, Vicente
    Facila, Lorenzo
    Quintanilla, Ma Amparo
    Rodriguez-Manero, Moises
    Escribano, David
    Valle, Alfonso
    de la Espriella, Rafael
    Torres-Llergo, Javier
    Bayes-Genis, Antoni
    Gonzalez-Juanatey, Jose R.
    AMERICAN JOURNAL OF THERAPEUTICS, 2022, 29 (05) : E572 - E575